Increased gastric cytokine production after Roux-en-Y gastric bypass for morbid obesity

Archives of Surgery

Volumn 142, Issue 10, 2007, Pages 962-968

  Faintuch, Joel ^a   Ishida, Robson K ^a   Jacabi, Mioko ^b   Ribeiro, Adriana S ^a   Kuga, Rogerio ^a   Sakai, Paulo ^a   Barbeiro, Hermes V ^a   Barbeiro, Denise F ^a   Soriano, Francisco G ^a   Cecconello, Ivan ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL COUNT; BACTERIAL OVERGROWTH; CLINICAL ARTICLE; COLON POUCH; COLONY FORMING UNIT; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MORBID OBESITY; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; ROUX Y ANASTOMOSIS; STOMACH; STOMACH BYPASS; STOMACH MUCOSA; UNIVERSITY HOSPITAL;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; GASTRIC MUCOSA; GASTRIC STUMP; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35349008507     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.142.10.962     Document Type: Article

References (38)

1. Mannon PJ, Fuss IJ, Dill S, et al. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology. 2006;131(3):748-756.
2. Hue S, Ahern P, Buonocore S, et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med. 2006;203(11):2473-2483 9.
3. Paajanen L, Kokkonen J, Karttunen TJ, Tuure T, Korpela R, Vaarala O. Intestinal cytokine mRNA expression in delayed-type cow's milk allergy. J Pediatr Gastroenterol Nutr. 2006;43(4):470-476.
4. Umehara Y, Kudo M, Nakaoka R, Kawasaki T, Shiomi M. Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis. Hepatogastroenterology. 2006;53(72):879-882.
5. Beltrán B, Nos P, Bastida G, Iborra M, Hoyos M, Ponce J. Safe and effective application of anti-TNF-α in a patient infected with HIV and concomitant Crohn's disease. Gut. 2006;55(11):1670-1671.
6. Camargo MC, Mera R, Correa P, et al. Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1674-1687.
7. Pritchard DM, Crabtree JE. Helicobacter pylori and gastric cancer. Curr Opin Gastroenterol. 2006;22(6):620-625.
8. Hsieh JS, Howng SL, Huang TJ, Wang JY, Chen FM. Endothelin-1, inducible nitric oxide synthase and macrophage inflammatory protein-1α in the pathogenesis of stress ulcer in neurotraumatic patients. J Trauma. 2006;61(4):873-878.
9. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm. 2006;74:443-477.
10. Ishida RK, Faintuch J, Sakai P, et al. Microbial counts of the stomach after Rouxen-Y gastric bypass (RYGBP) for morbid obesity [abstract]. Obes Surg. 2006;16(8):430.
11. Sakai P, Kuga R, Safatle-Ribeiro AV, et al. Is it feasible to reach the bypassed stomach after Roux-en-Y gastric bypass for morbid obesity? the use of the double-balloon enteroscope. Endoscopy. 2005;37(6):566-569.
12. Kuga R, Safatle-Ribeiro AV, Faintuch J, et al. Endoscopic findings in the excluded stomach after Roux-en-Y gastric bypass surgery. Arch Surg. 2007;142(10):942-946.
13. Misliver PB, Beuchat LR, Cousin MA. Yeasts and molds. In: Vanderzant C, Splittstoesser DF, eds. Compendium of the Microbiological Examination of Foods. 3rd ed. Washington, DC: American Public Health Association; 1992:239-249.
14. Dal-Pizzol F, Di Leone LP, Ritter C, et al. Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. Am J Respir Crit Care Med. 2006; 173(1):84-90.
15. Dixon JB, O'Brien PE. Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg. 2006;16(3):251-257.
16. Li Z, Li J. Local expressions of TGF-β1, TGF-β1RI, CTGF, and Smad-7 in Helicobacter pylori-associated gastritis. Scand J Gastroenterol. 2006;41(9):1007-1012.
17. Xing C, Kato S, Matsukura N, et al. Interleukin-8, cyclo-oxygenase-2, and trefoil factor family 1 gene expression and their association with Helicobacter pylori infection in the remnant stomach. Surg Today. 2005;35(12):1026-1032.
18. Shimizu T, Haruna H, Ohtsuka Y, Kaneko K, Gupta R, Yamashiro Y. Cytokines in the gastric mucosa of children with Helicobacter pylori infection. Acta Paediatr. 2004;93(3):322-326.
19. D'Elios MM, Amedei A, Benagiano M, Azzurri A, Del Prete G. Helicobacter pylori, T cells and cytokines: the "quot;dangerous liaisons."quot; FEMS Immunol Med Microbiol. 2005;44(2):113-119.
20. Shih SC, Tseng KW, Lin SC, et al. Expression patterns of transforming growth factor-beta and its receptors in gastric mucosa of patients with refractory gastric ulcer. World J Gastroenterol. 2005;11(1):136-141.
21. 3 inhibits pentagastrin-stimulated gastric acid secretion in rats. Med Sci Monit. 2005;11(3):BR80-BR83.
22. Monteleone G, Del Vecchio Blanco G, Palmieri G, et al. Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection. Gastroenterology. 2004;126(3):674-682.
23. Zavros Y, Merchant JL. Modulating the cytokine response to treat Helicobacter gastritis. Biochem Pharmacol. 2005;69(3):365-371.
24. Maciorkowska E, Panasiuk A, Kaczmarski M. Concentrations of gastric mucosal cytokines in children with food allergy and Helicobacter pylori infection. World J Gastroenterol. 2005;11(43):6751-6756.
25. Klausz G, Tiszai A, Lenart Z, et al. Helicobacter pylori-induced immunological responses in patients with duodenal ulcer and in patients with cardiomyopathies. Acta Microbiol Immunol Hung. 2004;51(3):311-320.
26. Sinha I, Cho BS, Roelofs KJ, Stanley JC, Henke PK, Upchurch GR Jr. Female gender attenuates cytokine and chemokine expression and leukocyte recruitment in experimental rodent abdominal aortic aneurysms. Ann N Y Acad Sci. 2006; 1085:367-379.
27. Wouters-Wesseling W, Vos AP, Van Hal M, De Groot LC, Van Staveren WA, Bindels JG. The effect of supplementation with an enriched drink on indices of immune function in frail elderly. J Nutr Health Aging. 2005;9(4):281-286.
28. Wu CY, Wu MS, Chen YJ, Chen CJ, Lin JT, Chen GH. Influence of COX-2 and local cytokine expressions in gastric ulcer mucosa by H pylori and NSAID. Hepatogastroenterology. 2006;53(71):797-803.
29. Li MO, Sanjabi S, Flavell RA. Transforming growth factor-β controls development, homeostasis and tolerance of T cells by regulatory T-cell dependent and independent mechanisms. Immunity. 2006;25(3):455-471.
30. Carrier Y, Yuan J, Kuchroo VK, Weiner HL. Th3 cells in peripheral tolerance, II: TGF-β-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity. J Immunol. 2007;178(1):172-178.
31. Khitin L, Roses RE, Birkett DH. Cancer in the gastric remnant after gastric bypass: a case report. Curr Surg. 2003;60(5):521-523.
32. Babor R, Booth M. Adenocarcinoma of the gastric pouch 26 years after loop gastric bypass. Obes Surg. 2006;16(7):935-938.
33. Corsini DA, Simoneti CA, Moreira G, Lima SE, Garrido AB. Cancer in the excluded stomach 4 years after gastric bypass. Obes Surg. 2006;16(7):932-934.
34. de Roover A, Detry O, de Leval L, et al. Report of two cases of gastric cancer after bariatric surgery: lymphoma of the bypassed stomach after Roux-en-Y gastric bypass and gastrointestinal stromal tumor (GIST) after vertical banded gastroplasty. Obes Surg. 2006;16(7):928-931.
35. Trincado MT, del Olmo JC, Garcia Castano J, et al. Gastric pouch carcinoma after gastric bypass for morbid obesity. Obes Surg. 2005;15(8):1215-1217.
36. Escalona A, Guzman S, Ibanez L, Meneses L, Huete A, Solar A. Gastric cancer after Roux-en-Y gastric bypass. Obes Surg. 2005;15(3):423-427.
37. Yamaoka Y, Yamauchi K, Ota H, et al. Natural history of gastric mucosal cytokine expression in Helicobacter pylori gastritis in Mongolian gerbils. Infect Immun. 2005;73(4):2205-2212.
38. Romano M, Ricci V, Zarrilli R. Mechanisms of disease: Helicobacter pylori-related gastric carcinogenesis: implications for chemoprevention. Nat Clin Pract Gastroenterol Hepatol. 2006;3(11):622-632.